330 related articles for article (PubMed ID: 21900185)
1. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
[TBL] [Abstract][Full Text] [Related]
2. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
[TBL] [Abstract][Full Text] [Related]
3. Renal function trajectories and clinical outcomes in acute heart failure.
Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
[TBL] [Abstract][Full Text] [Related]
4. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
Gheorghiade M; Gattis Stough W; Adams KF; Jaffe AS; Hasselblad V; O'Connor CM
Am J Cardiol; 2005 Sep; 96(6A):18G-25G. PubMed ID: 16181819
[TBL] [Abstract][Full Text] [Related]
5. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
Masson S; Anand I; Favero C; Barlera S; Vago T; Bertocchi F; Maggioni AP; Tavazzi L; Tognoni G; Cohn JN; Latini R;
Circulation; 2012 Jan; 125(2):280-8. PubMed ID: 22139751
[TBL] [Abstract][Full Text] [Related]
7. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
[TBL] [Abstract][Full Text] [Related]
9. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
Felker GM; Mentz RJ; Teerlink JR; Voors AA; Pang PS; Ponikowski P; Greenberg BH; Filippatos G; Davison BA; Cotter G; Prescott MF; Hua TA; Lopez-Pintado S; Severin T; Metra M
Eur J Heart Fail; 2015 Dec; 17(12):1262-70. PubMed ID: 26333655
[TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
[TBL] [Abstract][Full Text] [Related]
12. Do cardiac troponins provide prognostic insight in hemodialysis patients?
Choy JB; Armstrong PW; Ulan RA; Campbell PM; Gourishankar S; Prosser CI; Tymchak WJ
Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin and outcome in acute heart failure.
Peacock WF; De Marco T; Fonarow GC; Diercks D; Wynne J; Apple FS; Wu AH;
N Engl J Med; 2008 May; 358(20):2117-26. PubMed ID: 18480204
[TBL] [Abstract][Full Text] [Related]
14. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
[TBL] [Abstract][Full Text] [Related]
15. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
[TBL] [Abstract][Full Text] [Related]
16. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.
Perna ER; Macin SM; Canella JP; Augier N; Stival JL; Cialzeta JR; Pitzus AE; Garcia EH; Obregón R; Brizuela M; Barbagelata A
Circulation; 2004 Oct; 110(16):2376-82. PubMed ID: 15477403
[TBL] [Abstract][Full Text] [Related]
17. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
[TBL] [Abstract][Full Text] [Related]
18. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
19. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
20. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
